The Daily Briefing
What’s coming up today and what you might have missed
AbbVie issues its fourth-quarter results. It comes the week after the US pharma giant was cleared by the European Commission to buy Allergan, the Botox maker, for $63 billion. Paul Colgan, Allergan’s site lead in Westport, said he did not expect this to result in any “material change” to his company’s operations in Ireland, where it employs about 2,000 people.
Unemployment data for January is released in the US. In December,...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Arm of BlackRock builds up €20m short bet that Glanbia shares will continue to fall
Food company’s stock price has swung up and down since start of pandemic with performance nutrition products hit hard
